Daily Health Pharmacy

Author: Roger Donoghue - Page 6

Roger Donoghue 19 January 2026 8
How to Follow Professional Society Safety Updates on Medications

How to Follow Professional Society Safety Updates on Medications

Learn how to track critical medication safety updates from ISMP, FDA, ASHP, and WHO to prevent preventable errors. Get practical steps, free resources, and expert insights to stay current without being overwhelmed.

View More
Roger Donoghue 18 January 2026 13
Statins in Liver Disease: Safety and Cardiovascular Benefits Explained

Statins in Liver Disease: Safety and Cardiovascular Benefits Explained

Statins are safe and beneficial for people with liver disease, reducing cardiovascular risk and even protecting the liver. Evidence shows they lower mortality, prevent bleeding, and are well-tolerated-even in cirrhosis.

View More
Roger Donoghue 17 January 2026 14
Causality Assessment for Adverse Drug Reactions: How the Naranjo Scale Works in Real-World Practice

Causality Assessment for Adverse Drug Reactions: How the Naranjo Scale Works in Real-World Practice

The Naranjo Scale is a simple, 10-question tool used worldwide to determine if a drug caused an adverse reaction. Learn how it works, where it shines, and why it's still essential in drug safety today.

View More
Roger Donoghue 15 January 2026 9
Managing Blood Sugar Levels: A1C Targets and Daily Glucose Monitoring

Managing Blood Sugar Levels: A1C Targets and Daily Glucose Monitoring

Learn how A1C targets and daily glucose monitoring work together to manage diabetes effectively. Understand personalized goals, CGM benefits, real-world challenges, and how to avoid common pitfalls.

View More
Roger Donoghue 14 January 2026 15
Cardiovascular Generics: What Safety Studies and Real-World Data Really Show

Cardiovascular Generics: What Safety Studies and Real-World Data Really Show

Cardiovascular generics save billions but raise safety questions. Real-world data shows they work for most people, but small risks exist - especially after switching. Here’s what the studies really say.

View More
Roger Donoghue 13 January 2026 13
Hiccups Triggered by Medications: Common Causes and Effective Remedies

Hiccups Triggered by Medications: Common Causes and Effective Remedies

Hiccups from medications like dexamethasone, opioids, and benzodiazepines are more common than you think. Learn the top causes, proven remedies, and what to do when home tricks don’t work.

View More
Roger Donoghue 12 January 2026 9
Quality concerns: when clinicians question generic manufacturing

Quality concerns: when clinicians question generic manufacturing

Clinicians are raising alarms about rising quality issues in generic drugs, especially those made overseas. Studies show higher rates of severe adverse events with Indian-made generics, and outdated manufacturing practices are causing dangerous shortages. Transparency and domestic production may be key to fixing the system.

View More
Roger Donoghue 11 January 2026 11
Pain Management Combinations: Available Generic Fixed-Dose Products

Pain Management Combinations: Available Generic Fixed-Dose Products

Generic fixed-dose pain combinations like tramadol/acetaminophen and ibuprofen/acetaminophen offer stronger relief than single drugs for acute pain. Learn which combos are available, how they work, their risks, and how to use them safely.

View More
Roger Donoghue 10 January 2026 0
Pharmacist Authority in Substitution: Legal Scope of Practice Across U.S. States

Pharmacist Authority in Substitution: Legal Scope of Practice Across U.S. States

Pharmacists can legally substitute generic drugs in all U.S. states, but therapeutic substitution rules vary widely. Learn how state laws shape medication access, cost savings, and patient safety.

View More
Roger Donoghue 9 January 2026 13
Future of Generic Combinations: Regulatory and Market Trends

Future of Generic Combinations: Regulatory and Market Trends

Generic combinations are transforming the pharmaceutical industry by combining multiple drugs into smarter, more effective formulations. Learn how regulatory shifts and market demand are driving growth in super generics, from inhalers to extended-release pills.

View More